CatalystWireBeta

Holding(s) In Company

In brief · summary, not quotable

Faron Pharmaceuticals Ltd announced a change in major holdings on March 12, 2026, where Timo Syrjälä, through Acme Investments SPF Sarl, acquired voting rights, resulting in a total holding of 13.90% of the voting rights, down from a previous holding of 14.96%. This change was triggered by an acquisition or disposal of voting rights and dividend payments in kind, with the total number of voting rights held now standing at 16,093,129.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your FARN notes

Faron Pharmaceuticals LtdCompany announcementMarch 12, 2026 at 16:30:00 EET

TR-1: Standard form for notification of major holdings

  • Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)
Non-UK issuerX
  • Reason for the notification (please mark the appropriate box or boxes with an “X”)
An acquisition or disposal of voting rightsx
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify) iii : Dividend payments in kind.x

Details of person subject to the notification obligation iv

NameTimo Syrjälä
City and country of registered office (if applicable)Monaco

Full name of shareholder(s) (if different from 3.) v

NameAcme Investments SPF Sarl
City and country of registered office (if applicable)Luxembourg
5. Date on which the threshold was crossed or reached vi :10.03.2026
6. Date on which issuer notified (DD/MM/YYYY):11.03.2026
  • Total positions of person(s) subject to the notification obligation
NameAcme Investments SPF Sarl
City and country of registered office (if applicable)Luxembourg
Resulting situation on the date on which threshold was crossed or reached13.9013.9016.093.129
Position of previous notification (if applicable)14.9614.9617.120.400
A: Voting rights attached to shares
Class/type of shares ISIN code (if possible)Number of voting rights ix% of voting rights
Direct (DTR5.1)Indirect (DTR5.2.1)Direct (DTR5.1)Indirect (DTR5.2.1)
FI40001533095.745.11210.348.0174.96%8.94%
SUBTOTAL 8. A16.093.12913.90%

B 1: Financial Instruments according to DTR5.3.1R (1) (a)

SUBTOTAL 8. B 1

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)

SUBTOTAL 8.B.2

Timo Syrjälä (Direct)4.96%4.96%
Acme Investments SPF Sarl (Indirect)8.94 %8.94 %

In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

Additional information xvi

Place of completionMonaco
Date of completion11.3.2026

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note